MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessorie… Read more
MicroPort Endovascular MedTech Ltd (688016) - Total Assets
Latest total assets as of September 2025: CN¥4.73 Billion CNY
Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) holds total assets worth CN¥4.73 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MicroPort Endovascular MedTech Ltd - Total Assets Trend (2016–2024)
This chart illustrates how MicroPort Endovascular MedTech Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MicroPort Endovascular MedTech Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
MicroPort Endovascular MedTech Ltd's total assets of CN¥4.73 Billion consist of 63.9% current assets and 36.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 50.6% |
| Accounts Receivable | CN¥256.12 Million | 6.0% |
| Inventory | CN¥266.40 Million | 6.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥600.83 Million | 14.0% |
| Goodwill | CN¥435.88 Million | 10.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how MicroPort Endovascular MedTech Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MicroPort Endovascular MedTech Ltd's current assets represent 63.9% of total assets in 2024, an increase from 40.4% in 2016.
- Cash Position: Cash and equivalents constituted 50.6% of total assets in 2024, up from 14.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, a decrease from 27.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 14.0% of total assets.
MicroPort Endovascular MedTech Ltd Competitors by Total Assets
Key competitors of MicroPort Endovascular MedTech Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
MicroPort Endovascular MedTech Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MicroPort Endovascular MedTech Ltd generates 0.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, MicroPort Endovascular MedTech Ltd generates $ 11.70 in net profit.
MicroPort Endovascular MedTech Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.75 | 6.01 | 10.44 |
| Quick Ratio | 4.36 | 5.49 | 9.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.31 Billion | CN¥ 2.57 Billion | CN¥ 1.08 Billion |
MicroPort Endovascular MedTech Ltd - Advanced Valuation Insights
This section examines the relationship between MicroPort Endovascular MedTech Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.48 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | 1.1% |
| Total Assets | CN¥4.29 Billion |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Below Book Valuation: The market values MicroPort Endovascular MedTech Ltd's assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: MicroPort Endovascular MedTech Ltd's assets grew by 1.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for MicroPort Endovascular MedTech Ltd (2016–2024)
The table below shows the annual total assets of MicroPort Endovascular MedTech Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.29 Billion | +1.07% |
| 2023-12-31 | CN¥4.25 Billion | +112.83% |
| 2022-12-31 | CN¥2.00 Billion | +13.77% |
| 2021-12-31 | CN¥1.75 Billion | +27.43% |
| 2020-12-31 | CN¥1.38 Billion | +19.07% |
| 2019-12-31 | CN¥1.16 Billion | +329.93% |
| 2018-12-31 | CN¥268.82 Million | +19.87% |
| 2017-12-31 | CN¥224.26 Million | +18.91% |
| 2016-12-31 | CN¥188.60 Million | -- |